AlliancePharma Announces Granting of Options - KDA Group - Open Health

THETFORD MINES, QUEBEC–(Marketwired – Jan. 30, 2015) – AlliancePharma Inc. (“Alliance” or the “Corporation”) (TSX VENTURE:APA) granted an aggregate of 375,000 stock options an exercise price of $0.15 per share for a period of 5 years (the “Options“) to certain directors, employees and consultants in accordance with the Corporation’s Stock Option Plan. The Option grant is subject to approval from the TSX Venture Exchange.